Loading Video...
NTHRYS
Arrow

Drug–Gene and Drug–Drug–Gene Interactions Training | PGx Phenotypes, DDIs & Clinical Risk

NTHRYS >> Services >> Academic Services >> Training Programs >> Bioinformatics Training >> Pharmacogenomics, Pharmacometrics & Precision Therapeutics >> Drug–Gene and Drug–Drug–Gene Interactions Training | PGx Phenotypes, DDIs & Clinical Risk

Drug–Gene and Drug–Drug–Gene Interactions — Hands-on

Learn how pharmacogenomic phenotypes modify classic drug drug interactions and how to recognise high risk drug gene and drug drug gene combinations in practice. This module links metabolic and transporter phenotypes with inhibitors, inducers and polypharmacy patterns to support safer, interaction aware prescribing.

Drug–Gene and Drug–Drug–Gene Interactions
Help Desk · WhatsApp
Session 1
Fee: Rs 8800
Fundamentals of Drug–Gene Interactions
  • What is a drug–gene interaction in PGx context
  • gene driven PK variation PD targets and receptors efficacy and toxicity outcomes
  • Role of metabolic and transporter phenotypes
  • CYP poor vs ultra rapid metabolizers SLCO and ABC transporters baseline exposure differences
  • Concept of gene based dose thresholds and windows
  • narrow therapeutic index drugs up titration and monitoring when PGx is critical
Session 2
Fee: Rs 11800
Drug–Drug and Drug–Drug–Gene Interactions
  • Classic PK based drug–drug interactions (DDI)
  • inhibition and induction competitive and mechanism based time course of effect
  • What changes in a drug–drug–gene interaction (DDGI)
  • phenotype plus inhibitor scenario phenoconversion concept overlap of multiple pathways
  • Simple mental models for DDGI risk levels
  • high risk phenotypes with strong inhibitors compensation by parallel pathways when to consider alternatives
Session 3
Fee: Rs 14800
Clinical Scenarios & Risk Stratification
  • Polypharmacy examples with PGx phenotypes
  • antidepressants and pain medicines antiplatelets and PPIs statins with interacting drugs
  • Risk stratification for exposure and toxicity
  • low vs moderate vs high risk combinations patient factors and comorbidities role of TDM where available
  • Interaction checking tools with PGx awareness (concept)
  • standard DDI checkers adding phenotype overlays flagging and documentation
Session 4
Fee: Rs 18800
Mini Capstone: Interaction Aware PGx Summary
  • Worked case with gene, perpetrator and victim drugs
  • identify PGx phenotype map inhibitors and inducers estimate relative exposure change
  • Structuring an interaction aware PGx report section
  • summary paragraph interaction and risk table clear recommendation bullets
  • Deliverables: slide deck and one page interaction summary
  • PDF or PPTX re usable layout for clinical PGx services


PDF